As Japan prices take on greater global significance, disciplined launch strategy can help pharma companies capture the full value of innovation.
Na Wei
Advertisement
Partner with Simon-Kucher’s Life Sciences division in Tokyo
Articles by Na Wei
The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.
Advertisement
Latest Updated Articles
Pharma Forecasting: Key Markets Investors Can’t IgnoreDecember 13th 2024
MFN Raises the Stakes for Japan Launch PricingOctober 6th 2026
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
2
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
3
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
4
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
5